Andrew S. Artz, MD, MS, FASCO

Cancer.Net Associate Editor: Leukemia
City of Hope Comprehensive Cancer Center, Duarte, CA

Dr. Andrew Artz is a hematologist with an active practice managing patients with blood cancers and for those undergoing hematopoietic cell transplantation.  In August 2019, he commenced at the City of Hope (COH) as the first Director of the Program for Aging and Blood Cancers (ABC) after leaving the University of Chicago, where he served as Clinical Director of the Hematopoietic Cellular Therapy Program. He also serves as the Deputy Director of the Center for Cancer and Aging.

Dr. Artz’s career has focused on improving outcomes for older patients with hematologic conditions including anemia, myelodysplastic syndromes, and acute leukemias. He considers one of his greatest contributions to be a better understanding and treatment applying allogeneic hematopoietic cell transplantation for older adults with hematologic malignancy. A tremendous gap exists in this age group; they have low clinical trial participation (despite willingness) and less often undergo curative intent transplantation. He has established a multi-disciplinary team approach to evaluate and optimize this treatment for older patients, aiming to broaden access and improve outcomes.

View current ASCO disclosure here.

Last updated: February, 2021